Table 2.
Biochemical and hematological measurements of the study population.
| Variable | Ectatic (n = 65) |
Obstructive (n = 62) |
Control (n = 44) | p-Value |
|---|---|---|---|---|
| Total cholesterol, mg/dL | 185.14 ± 55.44 | 185.51 ± 54.55 | 190.39 ± 37.76 | 0.85 |
| Triglyceride, mg/dL | 155.89 ± 87.07 | 184.26 ± 128.43 | 159.69 ± 114.34 | 0.34 |
| HDL-C, mg/dL | 40.13 ± 10.15 | 38.67 ± 10.16 | 45.52 ± 11.97 | 0.007 |
| LDL-C, mg/dL | 116.61 ± 51.86 | 110.37 ± 44.03 | 117.86 ± 32.66 | 0.67 |
| Total cholesterol/HDL-C ratio | 4.76 ± 1.2 | 4.92 ± 1.11 | 4.15 ± 0.77 | 0.001 |
| Triglyceride/HDL-C ratio | 3.78 ± 2.24 | 4.67 ± 2.65 | 3.43 ± 2.76 | 0.03 |
| LDL-C/HDL-C ratio | 3.02 ± 1.76 | 2.87 ± 1.53 | 2.66 ± 1.03 | 0.001 |
| Hemoglobin, g/dL | 14.09 ± 1.76 | 13.37 ± 1.57 | 13.49 ± 1.63 | 0.049 |
| Hematocrit (%) | 41.38 ± 5.00 | 39.33 ± 4.45 | 39.67 ± 4.35 | 0.04 |
| Creatinine, mg/dL | 1.20 ± 0.80 | 1.12 ± 0.63 | 1.23 ± 0.88 | 0.74 |
Continuous variables are presented as mean ± standard deviation (SD). HDL-C, high-density lipoprotein cholesterol. LDL-C, low-density lipoprotein cholesterol.